Inflammatory diseases don’t boost clotting risks post-COVID, study reveals

Canadian researchers found that patients with immune-mediated inflammatory diseases (IMIDs) don’t face a heightened risk of venous thromboembolism events after recovering from COVID-19 compared to those without IMIDs. However, certain comorbidities can influence this risk, emphasizing the importance of individualized patient care.

Primary Care COPD Clinic Could Be a Model for Lasting Survival Benefit

A regional primary care, nonphysician-based program for chronic obstructive pulmonary disease (COPD) was associated with improved longer-term survival, a propensity-matched cohort study in Hong Kong

July 6, 2024

CMS lays out how seniors can pay for drugs on a monthly basis in 2025 and beyond

CMS laid out the first part of its plan to allow Medicare beneficiaries to pay for prescription drugs in monthly installments, as directed by the

August 23, 2023

Hospitals Grapple with Payment Delays, Two-Midnight Rule Expansion, and Outpatient Surgery Surge

– Hospitals and health systems nationwide saw a sizable increase in delayed or missing payments in the first quarter, due in part to a recent,

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.